Number of items: 14.
2024
Wei, L. , Butterly, E., Rodríguez Pérez, J. , Chowdhury, A., Shemilt, R., Hanlon, P. and McAllister, D.
(2024)
Description of subgroup reporting in clinical trials of chronic diseases: a meta-epidemiological study.
BMJ Open, 14(6),
e081315.
(doi: 10.1136/bmjopen-2023-081315)
(PMID:38908852)
Lees, J. S. et al.
(2024)
Participant characteristics and exclusion from trials: a meta-analysis of individual participant-level data from phase 3/4 industry-funded trials in chronic medical conditions.
BMJ Medicine, 3(1),
e000732.
(doi: 10.1136/bmjmed-2023-000732)
2023
Crowther, J. , Butterly, E. W., Hannigan, L. J. , Guthrie, B., Wild, S., Mair, F. S. , Hanlon, P. , Chadwick, F. J. and McAllister, D.
(2023)
Correlations between comorbidities in trials and the community: an individual-level participant data meta-analysis.
Journal of Multimorbidity and Comorbidity, 13,
pp. 1-9.
(doi: 10.1177/26335565231213571)
(PMID:37953975)
(PMCID:PMC10637135)
Hanlon, P. et al.
(2023)
Treatment effect modification due to comorbidity: individual participant data meta-analyses of 120 randomised controlled trials.
PLoS Medicine, 20(6),
e1004176.
(doi: 10.1371/journal.pmed.1004176)
(PMID:37279199)
(PMCID:PMC10243630)
Butterly, E. W. et al.
(2023)
Comorbidity and health-related quality of life in people with a chronic medical condition in randomised clinical trials: an individual participant data meta-analysis.
PLoS Medicine, 20(1),
e1004154.
(doi: 10.1371/journal.pmed.1004154)
(PMID:36649256)
(PMCID:PMC9844862)
2022
Hanlon, P. , Butterly, E., Shah, A. S. V., Hannigan, L. J. , Wild, S. H., Guthrie, B., Mair, F. S. , Dias, S., Welton, N. J. and McAllister, D. A.
(2022)
Assessing trial representativeness using Serious Adverse Events: An observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data.
BMC Medicine, 20,
410.
(doi: 10.1186/s12916-022-02594-9)
(PMID:36303169)
(PMCID:PMC9615407)
Butterly, E. et al.
(2022)
Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocol.
BMJ Open, 12(10),
e066491.
(doi: 10.1136/bmjopen-2022-066491)
(PMID:36302574)
(PMCID:PMC9621152)
Hannigan, L. J. , Phillippo, D. M., Hanlon, P. , Moss, L. , Butterly, E. W., Hawkins, N. , Dias, S., Welton, N. J. and McAllister, D. A.
(2022)
Improving the estimation of subgroup effects for clinical trial participants with multimorbidity by incorporating drug class-level information in Bayesian hierarchical models: a simulation study.
Medical Decision Making, 42(2),
pp. 228-240.
(doi: 10.1177/0272989X211029556)
(PMID:34407672)
(PMCID:PMC8777306)
Lees, J. S. et al.
(2022)
Effect of age, sex, and morbidity count on trial attrition: meta-analysis of individual participant level data from phase 3/4 industry funded clinical trials.
BMJ Medicine, 1(1),
e000217.
(doi: 10.1136/bmjmed-2022-000217)
(PMID:36936559)
(PMCID:PMC9978693)
2021
Hanlon, P. , Jani, B. D. , Butterly, E., Nicholl, B. , Lewsey, J. , McAllister, D. A. and Mair, F. S.
(2021)
An analysis of frailty and multimorbidity in 20,566 UK Biobank participants with type 2 diabetes.
Communications Medicine, 1,
28.
(doi: 10.1038/s43856-021-00029-9)
(PMID:35602215)
(PMCID:PMC9053176)
McGurnaghan, S. J. et al.
(2021)
Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland.
Lancet Diabetes and Endocrinology, 9(2),
pp. 82-93.
(doi: 10.1016/S2213-8587(20)30405-8)
(PMID:33357491)
(PMCID:PMC7832778)
2020
Hanlon, P. , Faure, I., Corcoran, N. , Butterly, E., Lewsey, J. , McAllister, D. and Mair, F. S.
(2020)
Frailty measurement, prevalence, incidence, and clinical implications in people with diabetes: a systematic review and study-level meta-analysis.
Lancet Healthy Longevity, 1(3),
e106-e116.
(doi: 10.1016/S2666-7568(20)30014-3)
(PMID:33313578)
(PMCID:PMC7721684)
Hanlon, P. , Butterly, E., Lewsey, J. , Siebert, S. , Mair, F. S. and McAllister, D. A.
(2020)
Identifying frailty in trials: an analysis of individual participant data from trials of novel pharmacological interventions.
BMC Medicine, 18,
309.
(doi: 10.1186/s12916-020-01752-1)
(PMID:33087107)
(PMCID:PMC7579922)
Hanlon, P. , Fauré, I., Corcoran, N. , Butterly, E., Lewsey, J. , McAllister, D. A. and Mair, F. S.
(2020)
The identification and prevalence of frailty in diabetes mellitus and association with clinical outcomes: a systematic review protocol.
BMJ Open, 10(9),
e037476.
(doi: 10.1136/bmjopen-2020-037476)
(PMID:32873673)
(PMCID:PMC7467518)
This list was generated on Wed Oct 9 23:25:56 2024 BST.